Moderna will receive $25m upfront and is eligible for more than $400m in development, regulatory, and commercial milestones
A new report from the company urges pharmaceutical executives to approach AI adoption with trust, transparency and traceability, outlining how the technology can drive...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.